Last reviewed · How we verify
COVID-19 Vaccine AstraZeneca suspension for injection
COVID-19 Vaccine AstraZeneca suspension for injection is a Biologic drug developed by Jens D Lundgren, MD. It is currently FDA-approved.
At a glance
| Generic name | COVID-19 Vaccine AstraZeneca suspension for injection |
|---|---|
| Sponsor | Jens D Lundgren, MD |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
- Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity (PHASE2)
- National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- COVID-19 Vaccine AstraZeneca suspension for injection CI brief — competitive landscape report
- COVID-19 Vaccine AstraZeneca suspension for injection updates RSS · CI watch RSS
- Jens D Lundgren, MD portfolio CI
Frequently asked questions about COVID-19 Vaccine AstraZeneca suspension for injection
What is COVID-19 Vaccine AstraZeneca suspension for injection?
COVID-19 Vaccine AstraZeneca suspension for injection is a Biologic drug developed by Jens D Lundgren, MD.
Who makes COVID-19 Vaccine AstraZeneca suspension for injection?
COVID-19 Vaccine AstraZeneca suspension for injection is developed and marketed by Jens D Lundgren, MD (see full Jens D Lundgren, MD pipeline at /company/jens-d-lundgren-md).
What development phase is COVID-19 Vaccine AstraZeneca suspension for injection in?
COVID-19 Vaccine AstraZeneca suspension for injection is FDA-approved (marketed).